Atlas Trials

A Clinical Trial to Evaluate Effect of IBD0333 in Patients With Advanced Malignant Tumors

Clinical trial NCT06292208 · RECRUITING

Trial details

NCT number
NCT06292208
Sponsor
SUNHO(China)BioPharmaceutical CO., Ltd.
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
MTD
Start date
2024-03-09
Primary completion
2029-12-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.